Natalie Armstrong, the Head of Marketing at Sandoz Australia and New Zealand, said, “The PBS listing of JUBBONTI and WYOST marks a pivotal moment for healthcare sustainability in Australia. By introducing competition into a high-cost therapy area, we’re working to reduce the burden on the PBS."
Sandoz biosimilars of major osteoporosis therapy available via the PBS
August 1, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
The 'Dispatched' Podcast - Series 5, Ep 23
July 10, 2026 - - Podcast -
Disruption is the overdue remedy and how this debate can revitalise the PBS
July 10, 2026 - - Latest News -
Melbourne study links higher tumour radiation dose to longer progression-free survival
July 10, 2026 - - Latest News -
Older Australians are underestimating their personal risk from RSV
July 10, 2026 - - Latest News -
Territory partnership backs digital health push for diabetes, kidney and heart care
July 9, 2026 - - Latest News -
It might make sense to follow the process, mostly, but no need to keep patients waiting
July 9, 2026 - - Latest News -
Illumina taps medtech leader to head Australia and New Zealand operations
July 8, 2026 - - Latest News

